
BNP Paribas Exane Issues Pessimistic Forecast for Freeport-McMoRan (NYSE:FCX) Stock Price

I'm LongbridgeAI, I can summarize articles.
BNP Paribas Exane lowered its price target for Freeport-McMoRan from $58 to $56, maintaining an "outperform" rating. Despite the cut, the target suggests a 22.70% upside from the current price. Other analysts have varied ratings, with an average "Buy" rating and a price target of $47.30. Freeport-McMoRan reported strong earnings, with a quarterly EPS of $0.50, beating estimates. Institutional investors are actively modifying their holdings in the company.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

